DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20201570

Influence of dermatophytosis on quality of life: a cross sectional study from Kashmir Valley in North India

Shahnawaz Bashir, Iffat Hassan, Rabbanie T. Wani

Abstract


Background: Over the past few years, dermatophytosis tends to be prolonged and persistent which negatively affects quality of life and relationship of patients with other people. There is limited literature available on the impact of dermatophytosis on the quality of life (QoL). The aim of the study is to investigate the influence of dermatophytosis on QoL in affected patients and identifying the risk factors associated therein.

Methods: This was a cross-sectional study (descriptive study) in which 425 patients aged ≥18 years with dermatophytosis were included and evaluated for impact on QoL using dermatology life quality index (DLQI) questionnaire. Modified Kuppuswamy scale was also used for assessing the socioeconomic status of the study subjects. Independent t-test and ANOVA were used to find statistical associations between mean DLQI scores and various variables, wherever applicable.

Results: The mean DLQI score in our study was 13.93±6.26. Dermatophytosis was found to have a very large effect on the QoL in majority (55.5%) of our subjects followed by moderate effect in 29.5% cases. Mean DLQI was higher in patients with longer duration of disease, involvement of unexposed sites (groins, gluteal region, axillae), greater number of sites involved, more body surface area involved, pruritus, redness and burning sensation (p<0.05). Regarding socio-demographic related variables, Mean DLQI score was higher in females, rural people, in (20-39) years age group, and in patients belonging to upper middle class (p<0.05).

Conclusions: This study revealed significant impairment of QoL patients with dermatophytosis.


Keywords


Dermatophytosis, Dermatology life quality index, Tinea, Pruritus, Kuppuswamy scale

Full Text:

PDF

References


Klaus W, Lowell GA, Stephen KI, Gilchrest B, Paller AS, Leffell D. Superficial fungal infection: Dermatophytosis in: Shannon V, Heffernan Michael P, editors. Fitzpatrick’s Dermatology in General Medicine. 7th ed. USA: McGraw Hill Companies; 2008: 1807.

Nawal P, Patel S, Patel M, Soni S, Khandelwal N. A study of Superficial Mycoses in Tertiary care Hospital. Nat J Integ Res Med. 2012;3:95-9.

Chudasama V, Solanki H, Vadasmiya M, Javadekar T. A study of superficial mycosis in tertiary care hospital. Int J Sci Res. 2014;3:222-4.

Narasimhalu CR, Kalyani M, Somendar S. A cross-sectional, clinico-mycological research study of prevalence, aetiology, speciation and sensitivity of superficial fungal infection in Indian patients. J Clin Exp Dermatol Res. 2016;7:324.

Naglot A, Shrimali DD, Nath BK, Gogoi HK, Veer V, Chander J, et al. Recent trends of dermatophytosis in northeast India (Assam) and interpretation with published studies. Int J Curr Microbiol App Sci. 2015;4:111-20.

Rajagopalan M, Inamadar A, Mittal A, Miskeen AK, Srinivas CR, Sardana K, et al. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India). BMC Dermatol. 2018;18:6.

Brigida S, Muthiah N. Pediatric Sedation: Prevalence of Tinea Corporis and Tinea Cruris in Outpatient Department of Dermatology Unit of a Tertiary Care Hospital. J Pharmacol Clin Res. 2017;3:555602.

Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: An appraisal. Indian J Dermatol. 2017;62:227-36.

Narang T, Mahajan R, Dogra S. Dermatophytosis: Fighting the challenge: Conference proceedings and learning points. September 2-3, 2017, PGIMER, Chandigarh, India. Indian Dermatol Online J. 2017;8:527-33.

Wani RT. Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh's scale updated for 2019. J Family Med Prim Care. 2019;8:1846-9.

Finlay AY, Khan G. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6.

Abedini R, Hallaji Z, Lajevardi V, Nasimi M, Khaledi MK, Tohidinik HR. Quality of life in mild and severe alopecia areata patients. Int J Womens Dermatol. 2018;4:91-4.

The WHO. World Health Organization Quality of Life (WHOQOL). Geneva: WHO; 2012.

Sumathi S, Mariraj J, Shafiyabi S, Ramesh R, Krishna S. Clinico mycological study of dermatophytoses at Vijayanagar Instititute of Medical Sciences (VIMS), Bellary. Int J Pharm Biomed Res. 2013;41:32-4.

Gang JA, Sheng XX, Sheng BX, Min JW, Mei SG, Ying YD, et al. Quality of life of patients with scabies. J Eur Acad Dermatol Venereol. 2010;24:1187-91.

Nayak PB, Girisha BS, Noronha TM. Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India. Indian Dermatol Online J. 2018;9:165-9.

Narang T, Bhattacharjee R, Singh S, Jha K, Kavita, Mahajan R, et al. Quality of life and psychological morbidity in patients with superficial cutaneous dermatophytosis. Mycoses. 2019;62:680-5.

Stander S, Stumpf A, Osada N, Wilp S, Chatzigeorgakidis E, Pfleiderer B. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol. 2013;168:1273-80.

Hazarika N, Rajaprabha RK. Assessment of life quality index among patients with acne vulgaris in a suburban population. Indian J Dermatol. 2016;61:163‑8.

Raddadi AA, Jfri A, Samarghandi S, Matury N, Habibullah T, Alfarshoti M, et al. Psoriasis: correlation between severity index (PASI) quality of life index (DLQI) based on type of treatment. J Dermatol Surg. 2016;20:15-8.

Patro N, Panda M, Jena AK. The menace of superficial dermatophytosis on the quality of life of patients attending referral hospital in eastern India: a cross-sectional observational study. Indian Dermatol Online J. 2019;10:262-6.